RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 45.5501

Change

-0.92 (-1.98)%

Market Cap

N/A

Volume

7.25K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-14 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.27 (+0.97%)

USD 9.17B
QLD ProShares Ultra QQQ

-0.25 (-0.24%)

USD 7.84B
FNGU MicroSectors FANG+ Index 3X Le..

-6.00 (-1.09%)

USD 7.31B
SSO ProShares Ultra S&P500

+0.22 (+0.24%)

USD 5.60B
UPRO ProShares UltraPro S&P500

+0.25 (+0.29%)

USD 4.27B
TECL Direxion Daily Technology Bull..

+0.68 (+0.81%)

USD 3.10B
YINN Direxion Daily FTSE China Bull..

+1.59 (+6.80%)

USD 1.32B
USD ProShares Ultra Semiconductors

-0.53 (-0.83%)

USD 1.16B
UDOW ProShares UltraPro Dow30

+1.38 (+1.49%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul..

-7.17 (-8.29%)

USD 0.82B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.52 (+0%)

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.03 (0%)

USD 8.38B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

-0.55 (0%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.04 (+0%)

USD 0.20B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

-0.11 (0%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.55% 75% C 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.55% 75% C 86% B+
Trailing 12 Months  
Capital Gain -4.73% 20% F 24% F
Dividend Return 1.62% 71% C- 26% F
Total Return -3.11% 20% F 21% F
Trailing 5 Years  
Capital Gain 36.10% 67% D+ 69% C-
Dividend Return 3.89% 66% D+ 10% F
Total Return 39.99% 67% D+ 63% D
Average Annual (5 Year Horizon)  
Capital Gain 11.94% 30% F 69% C-
Dividend Return 12.24% 30% F 64% D
Total Return 0.30% 22% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.38% 97% N/A 34% F
Risk Adjusted Return 39.02% 67% D+ 53% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.